In RUNX1 carriers without HM with CH, TET2, PHF6, and BCOR were reported to be recurrently mutated in RUNX1-driven malignancies, suggesting that CH is a direct precursor to malignancy in RUNX1-driven HHMS [163]. Here, RUNX1 is linked to cyclic hematopoiesis.